Navigation Links
ALSIUS CORPORATION PREPARED TO INVALIDATE ZOLL TEMPERATURE MANAGEMENT PATENTS
Date:2/3/2009

IRVINE, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Alsius Corporation (Nasdaq: ALUS), the worldwide leader in intravascular temperature management (IVTM(TM)) therapies for critically ill patients, today announced that it is prepared to respond aggressively to the patent lawsuit brought against it by ZOLL Circulation, Inc., a subsidiary of ZOLL Medical Corporation (Nasdaq: ZOLL). Alsius was sued by ZOLL based on two temperature management patents ZOLL purchased from a defunct competitor of Alsius'. Alsius believes that its patents do not infringe on the ZOLL patents, and that ZOLL's core temperature management patents are invalid. Alsius believes that it retains a dominant patent position in intravascular cooling that, among other things, precludes any competitor from marketing an intravascular cooling catheter for therapeutic hypothermia in patients who have had cardiac arrest or heart attack. ZOLL has not yet sold temperature management products based on ZOLL's patents.

About Alsius Corporation

Alsius, the worldwide leader in intravascular temperature management, develops, manufactures and sells proprietary products to precisely control patient temperature in hospital critical care settings. Controlling body temperature, through cooling and warming, is becoming the standard of care for patients in select critical conditions and those undergoing a variety of surgical procedures. Alsius markets a comprehensive suite of catheter-based intravascular temperature management products that address the largely unmet clinical need for effective, accurate, easy-to-use and cost-effective control of body temperature in critical care patients. For more information, visit www.alsius.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to Alsius' future financial or business performance. These statements are not guarantees of future performance and involve risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including the risks described from time to time in Alsius' filings with the Securities and Exchange Commission. These risks include, but are not limited to, the fact that Alsius must raise additional funds before the end of the second quarter of 2009 to continue its operations and finance the litigation described herein, uncertainty in the market for sales of medical equipment, and uncertainty in any complex litigation such as the litigation between Alsius and ZOLL described herein. Alsius undertakes no duty to update any forward-looking statements made herein, except as required by law.


'/>"/>
SOURCE Alsius Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Alsius Corporation Pre-Announces Record Fourth Quarter and Full Year 2008 Revenue
2. Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress
3. Alsius Corporation to Host Third Quarter 2008 Financial Results Conference Call on November 6
4. Alsius Corporation Awarded Three-Year Agreement With Premier, Inc.
5. Alsius Corporation Awarded Three-Year Agreement with HealthTrust Purchasing Group
6. Alsius Corporation Awarded Three-Year Agreement With MedAssets Supply Chain Systems
7. Alsius Corporation Receives Regulatory Approval in China and Mexico
8. Alsius Corporation Reports Record Fourth Quarter and Full Year 2007 Financial Results
9. Alsius Corporation Announces Program for Early Exercise of Warrants
10. Alsius Corporation to Host Third Quarter 2007 Financial Results Conference Call/Webcast on November 13, 2007
11. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2017)... Los Angeles, California (PRWEB) , ... May 26, 2017 , ... ... Canadian senior citizens who visit a doctor for colds or respiratory issues that are ... note that excessive time pressure on doctors may be largely responsible for the problem ...
(Date:5/27/2017)... Rosa, CA (PRWEB) , ... May 27, 2017 , ... ... cause for concern, but a new study from the Osteoarthritis Initiative shows ... to developing knee osteoarthritis. Knowing this in advance may give doctors the opportunity to ...
(Date:5/26/2017)... Fairfax, VA (PRWEB) , ... May 26, 2017 ... ... is pleased to announce a new educational seminar to focus on current legislative ... Regulatory News(LEARN) seminar will begin at 1 p.m. Sunday, Sept. 10, and will ...
(Date:5/26/2017)... ... 26, 2017 , ... Boar’s Head Brand®, one of the ... Day entertaining that are sure to satisfy your guests’ flavor cravings, while adding ... cheeses featured in these refreshingly balanced recipes are packed with flavor, creating the ...
(Date:5/26/2017)... ... May 26, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... focusing on the Peace Agreements being discussed by President Donald Trump and the rest ... to try to speed up peace talks in the continuous battle between Israel and ...
Breaking Medicine News(10 mins):
(Date:5/8/2017)... May 8, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO)., ... ("WRB"), a health care service center company based ... WRB specializes in relationship management programs for leading pharmaceutical ... WRB will join Envoy Health ... services for manufacturers, biotech firms, and other service companies. ...
(Date:5/4/2017)... Tenn. , May 4, 2017  A ... Infection Control, Ultraviolet-C light as a ... Tru-D SmartUVC,s ability to reduce bioburden on anesthesia ... bioburden reduction on high-touch, complex medical equipment surfaces ... surgical infections. "This study further validates ...
(Date:5/4/2017)...   BioLife Solutions , Inc. (NASDAQ: ... proprietary clinical grade hypothermic storage and ... announced that the Company,s first quarter 2017 financial results ... 11, 2017, and that the Company will host a ... that afternoon. Management will provide an overview of the ...
Breaking Medicine Technology: